Elevance Health, Inc.
About Elevance Health, Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $199.1B
- Net income
- $5.7B
- Total assets
- $121.5B
- Market cap
- $90.2B
- Gross margin
- 89.4%
- Operating margin
- 3.6%
- Net margin
- 2.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $199.1B
- Cost of revenue
- $21.2B
- Gross profit
- $177.9B
- Operating expenses
- $170.7B
- Operating income
- $7.2B
- Income tax
- $1.0B
- Net income
- $5.7B
- EPS (basic)
- $25.28
- EPS (diluted)
- $25.21
Balance sheet
- Total assets
- $121.5B
- Current assets
- $63.0B
- Total liabilities
- $77.5B
- Current liabilities
- $41.0B
- Shareholders’ equity
- $44.0B
Cash flow
- Operating cash flow
- $4.3B
- Investing cash flow
- -$1.3B
- Financing cash flow
- -$1.7B
- Net cash flow
- $1.2B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $90.2B
- P/E ratio
- 16.6
- EPS (diluted)
- $25.21
- Dividend yield
- 1.65%
- Shares outstanding
- 215.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 30, 2001
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $5.7B in FY2025.
- Revenue grew 27% from FY2022 to FY2025.
- Gross margin of 89.4%, net margin 2.8%.
- Trading near its 52-week high.
- Pays a dividend yielding about 1.65% annually.
- Valued at a price-to-earnings (P/E) ratio of 16.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Elevance Health, Inc..
Write a review
News about Elevance Health, Inc.
News & sentiment via Polygon.io
